Posted on 04/12/2020 7:06:08 AM PDT by SeekAndFind
The two have never been mutually exclusive propositions.
So then it seems we have the best of both worlds here. Lets get started on the program.
__________________________
HCQ has been the solution to getting back to work for weeks now. The liberal anti-Trump crowd wants nothing of the kind. They need to stretch this out till November, thinking it will harm Trump and give Big Pharma time to come up with a very expensive drug.
Until the dispensed amount is gone, whether that’s 12 or 14 pills. At the end of the protection period, you get another set of pills and start over.
Until the disease is no longer in the environment. The drug has a half life of forty to sixty days after you stop taking it.
https://www.worldometers.info/coronavirus/country/us/
See “closed cases”
30,604 recovered/discharged
20,649 deaths
51,253 cases which had an outcome
Percentage of cases with outcome resulting in deaths 0.4029 or 40%
RE: The two have never been mutually exclusive propositions.
I know. It is the TREATMENT part that has a lot of effective evidence, both in clinical studies and in anecdotes everywhere.
It is the PROPHYLACTIC part that is hard to prove. It is based on observation ( e.g. Lupus patients who are in the HCQ regimen do not have cases of Covid-19 ).
But India is going to be one huge test for this *IF* they apply this en mass. This is a country 4 times our population.
That was my way of identifying "cases with outcomes" where the statistics are pretty scary.
We don’t need a vaccine, the disease would need a colony of a very specific species of bat to remain in the environment after it runs its course through humans.
And certainly a vaccine that doesn’t have a decade of testing would be effectively intentionally attempting to kill every diabetic it was given too.
Not that all the people advocating that irresponsible lunacy would have qualms about that.
But 250,000 more dead?
You’re nuts.
Not even close
800 mg day #1 in divided doses
400 mg every 7 days thereafter for seven weeks
I hear it may five some pretty vivid dreams....
If you look at those who die as a percentage of those who have contracted the disease and may still be under treatment, the incidence of death is of course much, much lower.
Once you get into the hospital you are in trouble. What does that tell us about the efficacy of hydroxychloroquin? Is it being used enough if it is effective? Should it be used much earlier in the course of the disease? Should the dose be greatly enhanced for those who are critically ill? Should we look elsewhere for a treatment drug?
What does this tell us about how our quarantine is succeeding? Is the tail wagging the dog? Should we be quarantining and protecting the old and the vulnerable and letting the young and the healthy go forth?
How far along is our testing?
We need more data!
Again not even close
i saw a rheumatic doctor who deals with lupus patients that take the drug- when he was asked about a shortage of hydroxy effecting lupus patients he said he was not to worried as the drug stays active in the body some 2 to 3 months after the person stops taking it.
Hydroxycholoquine stands alone as a prophylaxis. Get azirhromycin involved only in the treatment phase
Half life is a whopping 46 days!
Not a chance in hell this lock down goes past end of month if it even goes that far.
Really? Hmmmmm. Thats a new one. Are you presenting to us a case study? Maybe like the 1/ 1M people who developed viral induced cerebral hemorrhage. Just for giggles whats your source and whats the incidence of this horrible side effect.
Oh thank God. Dr Google. See the antiviral properties are for when there is a virus. So its a treatment. The prophylaxis is for when there is not an infection in the organism. Last thing we need to do is teach this little bastard virus resistance.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.